Prevalite (Upsher-Smith Laboratories, LLC)


Welcome to the PulseAid listing for the Prevalite drug offered from Upsher-Smith Laboratories, LLC. This Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Upsher-Smith Laboratories, LLC
NON-PROPRIETARY NAME: cholestyramine
SUBSTANCE NAME: CHOLESTYRAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SUSPENSION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1996-02-01
END MARKETING DATE: 0000-00-00


Prevalite HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPrevalite from Upsher-Smith Laboratories, LLC
LABELER NAME: Upsher-Smith Laboratories, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 4(g/5.5g)
START MARKETING DATE: 1996-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0245-0036_1788d34e-a160-474d-a759-65f487dc7634
PRODUCT NDC: 0245-0036
APPLICATION NUMBER: ANDA073263

Other CHOLESTYRAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cadila Healthcare LimitedCHOLESTYRAMINE
Eon Labs, Inc.cholestyramine light
Par Pharmaceutical, Inc.Cholestyramine
Physicians Total Care, Inc.Cholestyramine
Upsher-Smith Laboratories, Inc.Cholestyramine
Upsher-Smith Laboratories, LLCPrevalite
Zydus Pharmaceuticals (USA) Inc.CHOLESTYRAMINE